← Evidence map

TrialHuman vaccines & immunotherapeutics2013

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting.

Djordje Atanackovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23955093